Apofore

About:

Apofore is a developer of novel therapeutics for diabetes.

Description:

Apofore is developing novel therapeutics for Type 2 diabetes based on the naturally occurring protein, Apolipoprotein A-IV (apo A-IV). The company’s approach is based on the discovery by its scientific founder Patrick Tso, PhD, at the University of Cincinnati, of apo A-IV as an important regulator of insulin secretion and glucose homeostasis. Recombinant apo A-IV, the company’s lead therapeutic is in preclinical development.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)apofore.com

Founders:

Patrick Tso

Number of Employees:

1-10

Last Funding Date:

2011-08-01

IPO Status:

Private

Industries: